Early data suggests GLP-1 drugs, renowned for their ability to assist in weight loss, may have a powerful effect on treating ...

The regulator’s approval on Friday of Vyloy for gastric or gastroesophageal junction cancer makes it the first and only ...

The central repository of the drug and medication centre helps to navigate to different sections. Medindia's platform provides carefully curated details on generics, brand names, side-effects ...

Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence ...

After a prior rejection, Astellas can head into the weekend celebrating a class-first FDA approval for its new gastric cancer ...

Zolbetuximab — now with the brand name Vyloy — is a monoclonal antibody to treat patients with advanced gastric and ...

A study suggests that weight loss medications like Ozempic may help reduce the risk of overdose and alcohol intoxication in ...

Among these risks is a digestive disorder called gastroesophageal reflux disease (GERD). GERD occurs when stomach acid ...

A first-in-class anti-CD19 B-cell depleting agent was safe and demonstrated superior efficacy vs placebo in patients with ...

Dr Fares Qeadan, the paper’s primary author, explains to Popular Science that opioids and alcohol were chosen for the study because “both … interact with reward pathways in the brain that GLP-1 ...

Circle Pharma, Inc., a clinical-stage biopharmaceutical company dedicated to discovering and developing a new generation of macrocycle therapies, anno ...

“Parasitic infections, long-term use of acid-reducing drugs, alcoholism, and digestive issues all ... In 2022, Zydus Lifesciences got final approval from the USFDA to market cyanocobalamin injection.